Inogen, the Goleta-based maker of direct-to-consumer respiratory products, on April 27 reported fourth-quarter profit of $1.5 million. The company said it had net income of 7 cents per share. Earnings, adjusted for pretax gains, were 6 cents per share. Inogen, which produces oxygen concentrators for patients suffering from chronic respiratory conditions, posted revenue of $29.1 Read More →
Inogen has benefited from the October release of its Inogen at Home product, which is the lightest continuous-flow oxygen concentrator available to consumers. It successfully floated an additional 2.4 million shares sold by existing stockholders and has announced an expanded credit line with J.P. Morgan Chase.
With a curriculum that steers clear of heavy emphasis on typical MBA topics like accounting, the Master’s in Technology Management program will focus on the specific leadership and management skills needed by engineers and tech professionals.
Shares of Goleta-based Inogen climbed 4.3 percent in after-hours trading on Tuesday as the medical-device maker reported better-than-expected second-quarter revenue and profit. The company, which went public earlier this year, makes portable at-home oxygen concentrators. Its second-quarter revenue soared 50.8 percent to $30.4 million, beating the Capital IQ Consensus Estimate by $6.5 million. Product sales Read More →
Shares of Goleta-based Inogen soared 11.4 percent to $16.29 on May 14 after reporting stronger-than-expected profits and boosting its sales outlook for the year.
Medical device maker Inogen notched $18.2 million in profits, or $1.10 per diluted share, on $75.4 million in revenue last year, the Goleta firm said in its first earnings report as a public company.